Successful substitution of protease inhibitors with efavirenz in patients with undetectable plasma HIV-1 RNA levels: results of a prospective, randomized, multicenter, open-label study (DMP 266049)

被引：0
|
作者：
Becker, S
Rachlis, A
Gill, J
DeJesus, E
Pierone, G
Kirkland, L
Koosian, S
Farina, D
Labriola, D
Ruiz, N
Bessen, L
Villano, S
机构：
[1] Pacific Horizon Med Grp, San Francisco, CA USA
[2] Sunnybrook & Womens Coll, Hlth Sci Ctr, Toronto, ON, Canada
[3] So Alberta HIV Clin, Calgary, AB, Canada
[4] IDC Res Initiat, Altamonte Springs, FL USA
[5] Treasure Coast Infect Dis Consultants, Vero Beach, FL USA
[6] Burnside Clin, Columbia, SC USA
[7] Oceanview Internal Med, Long Beach, CA USA
[8] DuPont Pharmaceut Co, Wilmington, DE USA
来源：
AIDS | 2000年 / 14卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P21
引用
收藏
页码：S22 / S22
页数：1
相关论文
共 36 条
  • [1] HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study
    Carr, A
    Hudson, J
    Chuah, J
    Mallal, S
    Law, M
    Hoy, J
    Doong, N
    French, M
    Smith, D
    Cooper, DA
    [J]. AIDS, 2001, 15 (14) : 1811 - 1822
  • [2] A randomized, multicenter, open-label study of poly-l-lactic acid for HIV-1 facial lipoatrophy
    Carey, Dianne L.
    Baker, David
    Rogers, Gary D.
    Petoumenos, Kathy
    Chuah, John
    Easey, Nicole
    Mahon, Kirsty
    Cooper, David A.
    Emery, Sean
    Carr, Andrew
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2007, 46 (05) : 581 - 589
  • [3] Multicenter open-label randomized study on efficacy and tolerability of three therapeutic regimens using protease inhibitors in treatment-naive patients with advanced HIV infections
    Ladisa, N
    Perulli, LM
    Maggi, P
    Chirianni, A
    Resta, F
    Buccoliero, G
    Congedo, P
    Igletti, M
    Angarano, G
    Pastore, G
    [J]. XIII CONVEGNO NAZIONALE AIDS E SINDROMI CORRELATE, 2000, : 153 - 157
  • [4] Switching to Bictegravir/Emtricitabine/Tenofovir Alafenamide in Black Americans With HIV-1: A Randomized Phase 3b, Multicenter, Open-Label Study
    Hagins, Debbie
    Kumar, Princy
    Saag, Michael
    Wurapa, Anson K.
    Brar, Indira
    Berger, Daniel
    Osiyemi, Olayemi
    Hileman, Corrilynn O.
    Ramgopal, Moti N.
    McDonald, Cheryl
    Blair, Christiana
    Andreatta, Kristen
    Collins, Sean E.
    Brainard, Diana M.
    Martin, Hal
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2021, 88 (01) : 86 - 95
  • [5] The effect of nevirapine in combination with nelfinavir in heavily pretreated HIV-1-infected patients - A prospective, open-label, controlled, randomized study
    Jensen-Fangel, S
    Thomsen, HF
    Larsen, L
    Black, FT
    Obel, N
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2001, 27 (02) : 124 - 129
  • [6] Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
    Olayemi Osiyemi
    Salih Yasin
    Carmen Zorrilla
    Ceyhun Bicer
    Vera Hillewaert
    Kimberley Brown
    Herta M. Crauwels
    [J]. Infectious Diseases and Therapy, 2018, 7 : 147 - 159
  • [7] Pharmacokinetics, Antiviral Activity, and Safety of Rilpivirine in Pregnant Women with HIV-1 Infection: Results of a Phase 3b, Multicenter, Open-Label Study
    Osiyemi, Olayemi
    Yasin, Salih
    Zorrilla, Carmen
    Bicer, Ceyhun
    Hillewaert, Vera
    Brown, Kimberley
    Crauwels, Herta M.
    [J]. INFECTIOUS DISEASES AND THERAPY, 2018, 7 (01) : 147 - 159
  • [8] Discontinuation of Primary and Secondary Prophylaxis for Opportunistic Infections in HIV-Infected Patients Who Had CD4+ Cell Count <200 cells/mm3 But Undetectable Plasma HIV-1 RNA: An Open-Label Randomized Controlled Trial
    Chaiwarith, Romanee
    Praparattanapan, Jutarat
    Nuntachit, Nontakan
    Kotarathitithum, Wilai
    Supparatpinyo, Khuanchai
    [J]. AIDS PATIENT CARE AND STDS, 2013, 27 (02) : 71 - 76
  • [9] Efficacy and Safety of Switching to Dolutegravir With Boosted Darunavir in Virologically Suppressed Adults With HIV-1: A Randomized, Open-Label, Multicenter, Phase 3, Noninferiority Trial: The DUALIS Study
    Spinner, Christoph D.
    Kummerle, Tim
    Schneider, Jochen
    Cordes, Christiane
    Heiken, Hans
    Stellbrink, Hans-Jurgen
    Krznaric, Ivanka
    Scholten, Stephan
    Jensen, Bjorn
    Wyen, Christoph
    Viehweger, Marin
    Lehmann, Clara
    Sprinzl, Martin
    Stoehr, Albrecht
    Bickel, Markus
    Jessen, Heiko
    Obst, Wilfried
    Spornraft-Ragaller, Petra
    Khaykin, Pavel
    Wolf, Eva
    Boesecke, Christoph
    [J]. OPEN FORUM INFECTIOUS DISEASES, 2020, 7 (09):
  • [10] Monotherapy with Lopinavir/Ritonavir as Maintenance After HIV-1 Viral Suppression: Results of a 96-Week Randomized, Controlled, Open-Label, Pilot Trial (KalMo Study)
    Nunes, Estevao P.
    de Oliveira, Marilia Santini
    Mercon, Monica
    Zajdenverg, Roberto
    Faulhaber, Jose Claudio
    Pilotto, Jose Henrique
    Ribeiro, Jorge Eurico
    Norton, Michael
    Schechter, Mauro
    [J]. HIV CLINICAL TRIALS, 2009, 10 (06): : 368 - 374
1234